These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 10652975)
1. A clinician's response to the oral contraceptive thrombosis controversy. Speroff L Hum Reprod Update; 1999; 5(6):654-63. PubMed ID: 10652975 [TBL] [Abstract][Full Text] [Related]
2. The truth about oral contraceptives and venous thromboembolism. Shulman LP; Goldzieher JW J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular disease and combined oral contraceptives: reviewing the evidence and balancing the risks. Farley TM; Meirik O; Collins J Hum Reprod Update; 1999; 5(6):721-35. PubMed ID: 10652981 [TBL] [Abstract][Full Text] [Related]
4. Risk of venous thromboembolism with third-generation oral contraceptives: A review. Weiss G Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 2):295-301. PubMed ID: 9988833 [TBL] [Abstract][Full Text] [Related]
5. Venous thromboembolism and desogestrel- or gestodene-containing combination oral contraceptives: what are the facts? Contracept Rep; 1996 Apr; 7(1):3-6. PubMed ID: 12320047 [TBL] [Abstract][Full Text] [Related]
6. Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill. Black C; Kaye JA; Jick H Br J Clin Pharmacol; 2002 Jun; 53(6):637-40. PubMed ID: 12047488 [TBL] [Abstract][Full Text] [Related]
7. Changes in prescription patterns of oral contraceptives in a northern Italian province: relation with venous thromboembolism. Girolami A; Spiezia L; Vianello F; Girolami B; Fabris F Clin Appl Thromb Hemost; 2003 Apr; 9(2):125-30. PubMed ID: 12812381 [TBL] [Abstract][Full Text] [Related]
8. Thrombotic stroke and myocardial infarction with hormonal contraception. Lidegaard Ø; Løkkegaard E; Jensen A; Skovlund CW; Keiding N N Engl J Med; 2012 Jun; 366(24):2257-66. PubMed ID: 22693997 [TBL] [Abstract][Full Text] [Related]
9. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Lancet; 1995 Dec; 346(8990):1582-8. PubMed ID: 7500749 [TBL] [Abstract][Full Text] [Related]
10. The Transnational Study on Oral Contraceptives and the Health of Young Women. Methods, results, new analyses and the healthy user effect. Lewis MA Hum Reprod Update; 1999; 5(6):707-20. PubMed ID: 10652980 [TBL] [Abstract][Full Text] [Related]
12. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel? Meurer LN; Slawson JG J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554 [No Abstract] [Full Text] [Related]
13. Venous and arterial thrombosis during oral contraceptive use: risks and risk factors. Tanis BC; Rosendaal FR Semin Vasc Med; 2003 Feb; 3(1):69-84. PubMed ID: 15199494 [TBL] [Abstract][Full Text] [Related]
14. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations]. Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161 [No Abstract] [Full Text] [Related]
15. [Combined contraceptives and cardiovascular risk]. Belaisch J; Hommais-loufrani B Contracept Fertil Sex (Paris); 1987 Dec; 15(12 Suppl):1-8. PubMed ID: 12315199 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular events associated with different combined oral contraceptives: a review of current data. Hannaford P Drug Saf; 2000 May; 22(5):361-71. PubMed ID: 10830253 [TBL] [Abstract][Full Text] [Related]